Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

B-type natriuretic peptide as predictor of heart failure in patients with acute ST elevation myocardial infarction, single-vessel disease, and complete revascularization: follow-up study (CROSBI ID 157622)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Manola, Šime ; Pavlović, Nikola ; Radeljić, Vjekoslav ; Delić Brkljačić, Diana ; Pintarić, Hrvoje ; Štambuk, Krešimir ; Bulj, Nikola ; Trbušić, Matias ; Krčmar, Tomislav ; Lukinac, Ljerka B-type natriuretic peptide as predictor of heart failure in patients with acute ST elevation myocardial infarction, single-vessel disease, and complete revascularization: follow-up study // Croatian medical journal, 50 (2009), 5; 449-454. doi: 10.3325/cmj.2009.50.449

Podaci o odgovornosti

Manola, Šime ; Pavlović, Nikola ; Radeljić, Vjekoslav ; Delić Brkljačić, Diana ; Pintarić, Hrvoje ; Štambuk, Krešimir ; Bulj, Nikola ; Trbušić, Matias ; Krčmar, Tomislav ; Lukinac, Ljerka

engleski

B-type natriuretic peptide as predictor of heart failure in patients with acute ST elevation myocardial infarction, single-vessel disease, and complete revascularization: follow-up study

Aimwas to assess the concentration of B-type natriuretic peptide (BNP) as a predictor of heart failure in patients with acute ST elevation myocardial infarction (STEMI) who underwent primary percutaneous coronary intervention (PCI) with successful and complete revascularization. Out of a total of 220 patients with acute STEMI admitted to the Sisters of Mercy University Hospital in the period January 1 to December 31, 2007, only patients with acute STEMI undergoing primary PCI who had single vessel disease and were successfully revascularized were included in the study. Selected patients had no history of myocardial infarction or heart failure and a normal or near-normal left ventricular ejection fraction (≥50%) assessed by left ventriculography at admission. Only 58 patients met the inclusion criteria for the study. Out of those, 6 patients refused to participate in the study, and another 5 could not be followed up, so a total of 47 patients were evaluated. Blood samples were taken for measurement of BNP levels at admission, 24 hours later, and 7 days later. Patients were followed up for 1 year. The primary outcome was reduction in left ventricular ejection fraction (LVEF) to <50% after 1 year. Patients who developed echocardiographic signs of reduced systolic function defined as LVEF<50% had significantly higher values of BNP (≥80 pg/mL) at 24 hours (P = 0.001) and 7 days (P = 0.020) after STEMI and successful reperfusion. Patients who had BNP levels ≥80 pg/mL after 7 days were 21 times more likely to develop LVEF<50 (odds ratio, 20.8 ; 95% confidence interval, 2.2-195.2 ; P = 0.008). BNP can be used as a predictor of reduced systolic function in patients with STEMI who underwent successful reperfusion and had normal ejection fraction at admission.

B-type natriuretic peptide ; heart failure ; acute myocardial infarction

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

50 (5)

2009.

449-454

objavljeno

0353-9504

1332-8166

10.3325/cmj.2009.50.449

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost